Fig. 7.
Fig. 7. Differentiation of HL-60 cells towards macrophage-like cells by PMA. HL-60 cells were treated with 10−8 mol/L PMA for 6 days and SERCA expression was determined. (A) Immunoblot staining for SERCA 2b and SERCAPLIM using the IID8 and the PLIM430 antibodies, respectively. (B) Densitometric analysis of SERCA expression in PMA-treated cells. (□) SERCA 2b; (•) SERCAPLIM. (C) Induction of CD11c expression by PMA-treated HL-60 cells. (D and E) Selective inhibition of the PMA-induced overexpression of SERCAPLIM by dexamethasone. HL-60 cells were treated for 5 days with 10−8 mol/L PMA in the presence of various concentrations of the glucocorticoid dexamethasone. (D) Immunostaining for SERCA 2b and SERCAPLIM using the IID8 and PLIM430 monoclonal antibodies, respectively. (E) Densitometric analysis of the expression levels of (□) SERCA 2b and (▪) SERCAPLIM in cells treated with PMA and dexamethasone (100% refers to SERCA expression of cells treated with PMA only). Data represent the mean ± SEM of 6 experiments.

Differentiation of HL-60 cells towards macrophage-like cells by PMA. HL-60 cells were treated with 10−8 mol/L PMA for 6 days and SERCA expression was determined. (A) Immunoblot staining for SERCA 2b and SERCAPLIM using the IID8 and the PLIM430 antibodies, respectively. (B) Densitometric analysis of SERCA expression in PMA-treated cells. (□) SERCA 2b; (•) SERCAPLIM. (C) Induction of CD11c expression by PMA-treated HL-60 cells. (D and E) Selective inhibition of the PMA-induced overexpression of SERCAPLIM by dexamethasone. HL-60 cells were treated for 5 days with 10−8 mol/L PMA in the presence of various concentrations of the glucocorticoid dexamethasone. (D) Immunostaining for SERCA 2b and SERCAPLIM using the IID8 and PLIM430 monoclonal antibodies, respectively. (E) Densitometric analysis of the expression levels of (□) SERCA 2b and (▪) SERCAPLIM in cells treated with PMA and dexamethasone (100% refers to SERCA expression of cells treated with PMA only). Data represent the mean ± SEM of 6 experiments.

Close Modal

or Create an Account

Close Modal
Close Modal